Our research has been built on a history of excellence. We conduct basic, clinical, and outcomes research. Visit our research sections below for more information.
Deletion of bone marrow myeloperoxidase attenuates chronic kidney disease accelerated atherosclerosis
Anna Vachaparampil Mathew MBBS, published her work in the Journal of Biological Chemistry that explores the bone marrow myeloperoxidase in CKD atherosclerosis.
Lenar Yessayan, MD and H. David Humes, MD discuss their study that used extracorporeal selective cytopheretic device therapy, developed by Dr. Humes, which helped to wean two patients off ECMO.
Salim Hayek, MD and Subramaniam Pennathur, MD find that hospitalized patients with COVID have high levels of soluble urokinase receptor, a strong predictor of kidney injury.
Listen to Michigan Medicine's team of researchers from various disciplines discuss finding new treatments and new ways to prevent diabetic complications including diabetic kidney disease, diabetic neuropathy, and diabetic retinopathy.